<DOC>
	<DOCNO>NCT01429961</DOCNO>
	<brief_summary>Phase II trial Palliative Chemotherapy TS-1 Oxaliplatin Patients Advanced Hepatocellular Carcinoma</brief_summary>
	<brief_title>Trial Palliative Chemotherapy With TS-1 Oxaliplatin Patients With Advanced Hepatocellular Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>Age 18 year old ECOG performance score two less Child Pugh class Aâ€¢ Histologically cytologically confirm HCC clinical diagnosis HCC follow criterion meet History chronic hepatitis cirrhosis liver Typical feature HCC demonstrate dynamic imaging study , three phase compute tomography AFP level 200 ng/mL presence extrahepatic measurable lesion prior systemic therapy ( exclude sorafenib ) adequate marrow , liver , kidney function write informed consent prior systemic therapy ( exclude sorafenib ) hypersensitivity study drug active gastrointestinal bleeding malignancy within five year pregnant breastfeed female symptomatic brain leptomeningeal metastasis clinically significant heart disease interstitial pneumonia peripheral neuropathy grade one uncontrolled infection renal impairment prior use investigational drug therapy within 4 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>